148 related articles for article (PubMed ID: 2610684)
1. In vivo treatment with erythroid differentiation factor (EDF/activin A) increases erythroid precursors (CFU-E and BFU-E) in mice.
Shiozaki M; Sakai R; Tabuchi M; Eto Y; Kosaka M; Shibai H
Biochem Biophys Res Commun; 1989 Dec; 165(3):1155-61. PubMed ID: 2610684
[TBL] [Abstract][Full Text] [Related]
2. Effects of erythroid differentiation factor (EDF) on proliferation and differentiation of human hematopoietic progenitors.
Nakao K; Kosaka M; Saito S
Exp Hematol; 1991 Dec; 19(11):1090-5. PubMed ID: 1752318
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the participation of endogenous activin A/erythroid differentiation factor in the regulation of erythropoiesis.
Shiozaki M; Sakai R; Tabuchi M; Nakamura T; Sugino K; Sugino H; Eto Y
Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1553-6. PubMed ID: 1542647
[TBL] [Abstract][Full Text] [Related]
4. [Effects of erythroid differentiation factor on inhibition of erythroid colony-formation (CFU-E and BFU-E) by the sera and on BPA secretion by peripheral mononuclear cells in patients with chronic renal failure].
Shinohara M; Mizuguchi T; Kosaka M; Saito S
Rinsho Ketsueki; 1991 Nov; 32(11):1403-9. PubMed ID: 1758047
[TBL] [Abstract][Full Text] [Related]
5. Effect of erythroid differentiation factor on maintenance of human hematopoietic cells in co-cultures with allogenic stromal cells.
Nakamura K; Kosaka M; Mizuguchi T; Saito S
Biochem Biophys Res Commun; 1993 Aug; 194(3):1103-10. PubMed ID: 8352765
[TBL] [Abstract][Full Text] [Related]
6. Effects of human recombinant erythropoietin on differentiation and distribution of erythroid progenitor cells on murine medullary and splenic erythropoiesis during hypoxia and post-hypoxia.
Mide SM; Huygens P; Bozzini CE; Fernandez Pol JA
In Vivo; 2001; 15(2):125-32. PubMed ID: 11317516
[TBL] [Abstract][Full Text] [Related]
7. Diminished erythropoietin-induced erythroid growth in patients with renal anemia is restored by recombinant human erythroid differentiation factor.
Shimizu T; Kawano Y; Takaue Y; Kuroda Y
Am J Hematol; 1994 Nov; 47(3):178-82. PubMed ID: 7942781
[TBL] [Abstract][Full Text] [Related]
8. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
[TBL] [Abstract][Full Text] [Related]
9. Effects in vivo of recombinant human inhibin on myelopoiesis in mice.
Hangoc G; Carow CE; Schwall R; Mason AJ; Broxmeyer HE
Exp Hematol; 1992 Nov; 20(10):1243-6. PubMed ID: 1426104
[TBL] [Abstract][Full Text] [Related]
10. Stimulatory effect of human insulin on erythroid progenitors (CFU-E and BFU-E) in human CD34+ separated bone marrow cells and the relationship between insulin and erythropoietin.
Aoki I; Taniyama M; Toyama K; Homori M; Ishikawa K
Stem Cells; 1994 May; 12(3):329-38. PubMed ID: 7521243
[TBL] [Abstract][Full Text] [Related]
11. Long-term recombinant human granulocyte colony-stimulating factor (rhG-CSF) treatment severely depresses murine marrow erythropoiesis without causing an anemia.
de Haan G; Loeffler M; Nijhof W
Exp Hematol; 1992 Jun; 20(5):600-4. PubMed ID: 1375161
[TBL] [Abstract][Full Text] [Related]
12. Erythroid progenitor (BFU-E, CFU-E) proliferation as inferred from 5'bromodeoxyuridine labeling.
Hagan M; Patchen M; Weinberg S; MacVittie T
Exp Hematol; 1994 Dec; 22(13):1221-6. PubMed ID: 7957708
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of erythroid precursors in mice infected with the anemic or the polycythemic strain of Friend leukemia virus.
Peschle C; Migliaccio G; Lettieri F; Migliaccio AR; Ceccarelli R; Barba P; Titti F; Rossi GB
Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2054-8. PubMed ID: 6929538
[TBL] [Abstract][Full Text] [Related]
14. Regeneration of erythroid progenitor cells in polycythemic mice treated with cyclophosphamide.
Biljanović-Paunović L; Milenković P; Kapa D; Pavlović-Kentera V
Exp Hematol; 1985 Jan; 13(1):67-73. PubMed ID: 3972018
[TBL] [Abstract][Full Text] [Related]
15. Effects in vivo of purified recombinant human activin and erythropoietin in mice.
Broxmeyer HE; Hangoc G; Zucali JR; Mason A; Schwall R; Carow C; Cooper S
Int J Hematol; 1991 Dec; 54(6):447-54. PubMed ID: 1793828
[TBL] [Abstract][Full Text] [Related]
16. Improvement of erythroid toxicity by lentinan and erythropoietin in mice treated with chemotherapeutic agents.
Takatsuki F; Miyasaka Y; Kikuchi T; Suzuki M; Hamuro J
Exp Hematol; 1996 Feb; 24(3):416-22. PubMed ID: 8599970
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human erythroid potentiating activity enhances the effect of erythropoietin in mice.
Niskanen E; Gasson JC; Egrie J; Wipf K; Golde DW
Eur J Haematol; 1990 Nov; 45(5):267-70. PubMed ID: 2261953
[TBL] [Abstract][Full Text] [Related]
18. Effects of actinomycin D in vivo on murine erythroid stem cells.
Zuckerman KS; Sullivan R; Quesenberry PJ
Blood; 1978 May; 51(5):957-69. PubMed ID: 638254
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietic precursors in mice under erythropoietic stimulation and suppression.
Hara H; Ogawa M
Exp Hematol; 1977 Mar; 5(2):141-8. PubMed ID: 844518
[TBL] [Abstract][Full Text] [Related]
20. Effects of activin A/erythroid differentiation factor on erythroid and megakaryocytic differentiations of mouse erythroleukemia (Friend) cells: evidence for two distinct modes of cell response.
Okafuji K; Kaku K; Seguchi M; Tanaka H; Azuno Y; Kaneko T
Exp Hematol; 1995 Mar; 23(3):210-6. PubMed ID: 7875239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
